Bernstein Upgrades Edwards Lifesciences(EW.US) to Hold Rating, Raises Target Price to $74

Futu NewsJan 9 07:32 · Ratings

RBC Capital Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $85

Futu NewsJan 8 10:31 · Ratings

RBC Capital Reaffirms Their Buy Rating on Edwards Lifesciences (EW)

TipRanksJan 8 09:47 · Ratings

Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

BusinesswireJan 7 20:05

FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development

Seeking AlphaJan 7 01:52

Is Edwards Lifesciences (NYSE:EW) A Risky Investment?

Simply Wall StJan 6 20:15